Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Think Research Corporation
V.THNK
Healthcare
Medical Devices
Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical...
Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:THNK)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 14, 2023 5:00pm
New Press Release - Think Research Announces Results of Annual General Meeting
TORONTO, Aug. 14, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("TRC" or the "Company"), a company focused on transforming healthcare through digital health software solutions, today announced the results of its August 11, 2023 Annual General Meeting (the "Meeting") of shareholders. The...
read article.
(1962)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Aug 12, 2023 12:37am
RE:RE:shareholder proposal
The corporate proposals passed and the shareholder proposal , GC's, did not get enough support. Very short AGM , 18 minutes with nothing offered besides the legalities. No questions asked
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(18)
•••
dt_core
X
View Profile
View Bullboard History
Comment by
dt_core
on Aug 11, 2023 9:02am
RE:shareholder proposal
It'll be interesting to see the result of todays AGM. Having GC as a shareholder is a strong positive IMO given his investment style. He's about as activist as they come so I wouldn'
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 04, 2023 5:48pm
New Press Release - TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Aug. 4, 2023 /CNW/ -TSX VENTURE COMPANIESCANADA ONE MINING CORP. ("CONE") BULLETIN TYPE: Resume Trading BULLETIN DATE: August 4, 2023 TSX Venture Tier 2 CompanyFurther to the Exchange Bulletin dated September 17, 2021, news releases were issued on April 25, 2023 and...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 01, 2023 7:10am
New Press Release - Think Research Announces Shares for Debt Transaction
TORONTO, Aug. 1, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("TRC" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that, pursuant to the release on May 1, 2023, the Company has agreed to issue C$56,250 in...
read article.
(1962)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jul 27, 2023 9:51pm
shareholder proposal
There's a shareholder proposal to do away with the advanced notice bylaw. The interesting thing is the shareholder is George Christopoulos as in . AVANTE LOGIXX INC. SECOND LARGEST SHAREHOLDER
...more
(18)
•••
dt_core
X
View Profile
View Bullboard History
Post by
dt_core
on Jul 26, 2023 1:24pm
SA Toronto Star Article
The Toronto company helping doctors stay at the top of their game Think Research has developed digital tools that let health care professionals quickly access the latest best practices
...more
(18)
•••
dt_core
X
View Profile
View Bullboard History
Comment by
dt_core
on Jul 26, 2023 12:52pm
RE:Dialogue Health
Someday it'll be THNKs turn to be aquired, but not yet.
(1962)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jul 26, 2023 9:10am
Dialogue Health
Bought cheaply by Sun Life for $5.15 a share
(248)
•••
pacer217
X
View Profile
View Bullboard History
Post by
pacer217
on Jul 20, 2023 9:58pm
Strange BID / ASK..
Early Thursday there was a sizeable BID of 150 lots ; @.325 --about 4 to 1 against what was offered. Yet, surprising, it did not get touched. Some one else bought a block @ the Ask price..
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 18, 2023 7:15am
New Press Release - Think Research's Pharmapod Selected by Neighbourly Pharmacy to Manage Medication Safety for Nearly 300 Locations Across Canada
TORONTO, July 18, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("TRC" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that Pharmapod, Think's medication incident management solution has been selected by...
read article.
(18)
•••
dt_core
X
View Profile
View Bullboard History
Comment by
dt_core
on Jul 14, 2023 10:09am
RE:RE:New SAAS Contracts
I've been wrong before too, which is why I always take any insights I hear with a grain of salt. On another topic it's really interesting to run the number son what a potential WELL
...more
(1962)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Jul 13, 2023 4:59pm
RE:New SAAS Contracts
You've been right before ; hopefully you are this time:) On the other hand , given the performance since the IPO , IMO , there's probably a massive supply of shares that investors are going to
...more
(18)
•••
dt_core
X
View Profile
View Bullboard History
Post by
dt_core
on Jul 12, 2023 3:39pm
New SAAS Contracts
Some speculation that THNK will announce two brand new SAAS related contracts sometime over the next few weeks or so. One is around $2M annually but has potential to go to $4M and the other is $3.5M
...more
(18)
•••
dt_core
X
View Profile
View Bullboard History
Comment by
dt_core
on Jul 10, 2023 9:54pm
RE:RE:RE:Echelon - Top 5 pick - cantechletter.com
Steve has walked away from mentioning all his past picks but he still owns THNK in his funds. I hear you that some investor interest is needed to jolt the stock back to life - making the Top Buy list
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >